<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

5 min read

Treading Water: Q120 US Surgical Matrices Market Recap

7/9/20 10:21 AM

Q120 Surgical MatricesThe US Surgical Matrices Market treaded water in Q120, up +1.6%, as the impact of COVID-19 began to be felt broadly at the end of a quarter that had initially started with good growth.

In Q120, the US Surgical Matrices Market grew +1.6% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan* maintained its lead despite the slowdown in breast augmentation and reconstruction surgeries due to COVID-19, gaining +3.4% YoY. Becton Dickinson* (BD) also had been growing well until COVID-19 slowed hernia surgeries, and, like many other companies, warned that Q220 would be far worse since the impact of COVID-19 would be felt at the beginning of the quarter.

Among the many topics covered in the comprehensive Q120 US Surgical Matrices Market Recap* are:

  • Complete Market Overview with Company Revenues and Shares
  • US Breast Matrices: COVID-19 Nearly Erases Growth
  • US Hernia Repair Matrices Market: Modest Growth Again
  • Other Q120 US Surgical Matrices Market Events

The US Surgical Matrices market grew modestly in both the Breast Reconstruction and Hernia Repair segments, with both segments experiencing good growth until surgeries began to be delayed in mid- to late March due to the impact of COVID-19. For the quarter, the Breast segment managed to grow +2.4% YoY to $XXX Blurred-1 with 34.9% share of the Surgical Matrices market in Q120. The Hernia Repair segment grew less, with +1.2% YoY growth to $XXX Blurred-1 and 65.1% share of the US Surgical Matrices Market in Q120...

Read the entire Q120 OrthoBio Market Recap including news, data, charts, company revenues and analysis*...

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

Learn More

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Recent Articles